Institut für Klinische Krebsforschung IKF GmbH

Academic/Hospital

Also known as: Frankfurter Institut für Klinische Krebsforschung IKF GmbH | Institut für Klinische Krebsforschung IKF GmbH | Institut für Klinische Krebsforschung IKF GmbH, Frankfurt, Germany

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 27, 2017

Last known activity

Nov 18, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (41 distinct, 24 trials)

Phase 4 (1 own, 0 via acquisition)

trabectedin

Phase 3 (7 own, 0 via acquisition)

Phase 2 (33 own, 0 via acquisition)

Indications

Studied for

Recent trials (27)

NCT07260175OfficialPhase 2Nov 18, 2025
NCT07255664CollaboratorPhase 1/Phase 2Nov 13, 2025
NCT07176312OfficialPhase 2Oct 31, 2025
NCT07110038OfficialPhase 2Oct 31, 2025
NCT07059299OfficialPhase 1Aug 31, 2025
NCT06981325OfficialPhase 2Aug 7, 2025
NCT06899477CollaboratorPhase 3Apr 30, 2025
NCT06856837OfficialPhase 2Apr 1, 2025
NCT06722183OfficialPhase 2Mar 31, 2025
NCT06731803OfficialPhase 1/Phase 2Mar 1, 2025
NCT06680622OfficialPhase 2Dec 31, 2024
NCT06207734OfficialPhase 2Jan 17, 2024
NCT06123468Study directorPhase 1/Phase 2Dec 31, 2023
NCT05713838OfficialPhase 2Aug 28, 2023
NCT05713838Study chairPhase 2Aug 28, 2023

Details

Last known activity: Nov 18, 2025